Business
Insulet Reports First Quarter 2025 Revenue Increase of 29% Year-Over-Year (30% Constant Currency1)
ACTON, Mass., May 08, 2025--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2025.
About this update from Insulet Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":236,"url":"https://media.zenfs.com/en/business-wire.com/0386bbd35af9b994d67ca6cac38470e1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YpBO9cJvvttJ2Fskz3gIkw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ3MjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/0386bbd35af9b994d67ca6cac38470e1","width":480,"height":236}},"lazy":false},{"type":"text","content":"Raising Full Year Revenue and Gross Margin Guidance","length":51,"tagName":"p","attribs":{}},{"type":"text","content":"ACTON, Mass., May 08, 2025--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2025.","length":273,"tagName":"p"},{"type":"text","content":""Our first quarter results showcase the strong execution and dedication of the Insulet team, who has continued to expand the reach of Omnipod 5 technology to people living with diabetes globally. As Insulet's new President and CEO, I see a path to scale the Company from an emerging diabetes leader to a durable growth engine, driving an even greater impact for our partners, stakeholders, and most importantly, our Podders," said Ashley McEvoy, President and CEO. "I’d like to thank the team and Board of Directors for their incredible support. Insulet is just getting started on an exciting journey to revolutionize diabetes management globally. I am energized and honored to embark on that journey with all of you."","length":742,"tagName":"p"},{"type":"text","content":"First Quarter Financial Highlights:","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $569.0 million, up 28.8%, or 29.8% in constant currency, compared with $441.7 million in the prior year, exceeds the high end of the Company’s guidance range of 25% in constant currency","length":196,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Total Omnipod revenue of $554.1 million, an increase of 28.0%, or 29.0% in constant currency","length":92,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"U.S. Om...